Results 121 to 130 of about 17,734 (168)

Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy? [PDF]

Haematologica
Dann EJ.
europepmc   +1 more source

Systemic Therapy for Solitary Fibrous Tumor. [PDF]

Curr Treat Options Oncol
Stergiopoulos GM, Tinoco G, Robinson SI.
europepmc   +1 more source

Radiological Response to Capecitabine and Temozolomide in an Elderly Patient with Metastatic Leiomyosarcoma: A Case Report. [PDF]

J Clin Med
Yalcin S, Kilinc C, Sahin TK, Dizdar O.
europepmc   +1 more source

Matching-adjusted indirect treatment comparison of A+AVD vs PET-guided ABVD in newly diagnosed advanced Hodgkin lymphoma. [PDF]

Future Oncol
Kristo F, Molinari A, Lan Z, Paly V, Khan R, Poirier A, Moradian H, Savani BN, Zomas A, Ashaye A.   +9 more
europepmc   +1 more source

Validation of the newly introduced Deauville score 5a for patients treated for advanced-stage classic Hodgkin lymphoma. [PDF]

Blood Adv
Leiders S, Ufton D, Kaul H, Weindler J, Rosenbrock J, Fuchs M, Dietlein M, Novak U, Fehr M, Greil R, Hertzberg M, Zijlstra JM, Fosså A, Kamper P, Molin D, Borchmann P, Kobe C, Ferdinandus J.   +17 more
europepmc   +1 more source

Exploring Dacarbazine Complexation with a Cellobiose-Based Carrier: A Multimethod Theoretical, NMR, and Thermochemical Study. [PDF]

Molecules
Hoelm M, Kinart Z, Porwański S.
europepmc   +1 more source

Photodynamic therapy enhances dacarbazine sensitivity of melanoma cells by induction of apoptosis and downregulation of PI3K/AKT signaling pathway. [PDF]

Sci Rep
Hajizadeh M, Doustvandi MA, Mohammadnejad F, Khiabani NA, Nobari SA, Oskouei SSS, Tajalli H, Mehdizadehfar E, Baradaran B.   +8 more
europepmc   +1 more source

Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System and Systemic Classic Hodgkin Lymphoma in the Same Patient. [PDF]

J Hematol
Al Kurnas M, Paludo J, Larson DP, Begna KH.   +3 more
europepmc   +1 more source

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma. [PDF]

Blood Adv
Övergaard N, Lia K, Collin J, Asdahl PH, Wikman P, Glimelius I, Lagerlöf I, Johansson AS, Hansson L, Enblad G, Linderoth J, Goldkuhl C, Jerlström U, Fosså A, Kamper P, Molin D.   +15 more
europepmc   +1 more source

The AKT-p21 phosphorylation signaling axis confers poor prognosis and dacarbazine resistance in melanoma. [PDF]

Sci Rep
Colaneri GN, Monteiro AC, Tonin BCB, Azevedo H, Alves-Fernandes DK, da Cruz AT, Meliso FM, Morais AS, Stilhano RS, Gross S, Ostalecki C, Schneider-Stock R, Han SW, Jasiulionis MG.   +13 more
europepmc   +1 more source